Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Drug reaction with eosinophilia and systemic symptoms (DReSS), also known as drug-
induced hypersensitivity syndrome (DiHS), is a severe, systemic, T cell mediated drug …

Aims: To compare the clinical profile of patients diagnosed as definite/probable DRESS by
the Registry of Severe Cutaneous Adverse Reaction (RegiSCAR) scoring system and as …

Background Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe
adverse drug reaction generally accompanied by skin manifestations as the first and most …

Recurrence of DRESS syndrome is poorly characterized, and dermatologists must be
prepared to predict, identify, and manage patients after treatment of the initial presentation …

Background Detailed scoring systems such as the European Registry of Severe Cutaneous
Adverse Reactions (RegiSCAR) score for validating a diagnosis of drug reaction with …

Aims Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare, drug‐
induced severe adverse reaction that usually occurs 3–6 weeks after initial exposure to …

Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe adverse
cutaneous drug reaction with mortality up to 10%. It is a rare condition with risk varying …

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a rare and
severe adverse drug reaction involving multiple organs. Data on DRESS syndrome among …

Background: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare
drug reaction characterized by a skin rash, eosinophilia, and organ involvement. Objective …